Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry.
about
PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein BBimolecular complementation defines functional regions of Herpes simplex virus gB that are involved with gH/gL as a necessary step leading to cell fusionAnalysis of a neutralizing antibody for human herpesvirus 6B reveals a role for glycoprotein Q1 in viral entryStructure of a trimeric variant of the Epstein-Barr virus glycoprotein BAntigenic and mutational analyses of herpes simplex virus glycoprotein B reveal four functional regionsHerpes simplex virus type 1 mediates fusion through a hemifusion intermediate by sequential activity of glycoproteins D, H, L, and BViruses Utilize Cellular Cues in Distinct Combination to Undergo Systematic Priming and UncoatingRetargeting Strategies for Oncolytic Herpes Simplex VirusesHerpesvirus gB: A Finely Tuned Fusion MachineRandom linker-insertion mutagenesis to identify functional domains of herpes simplex virus type 1 glycoprotein BStructures and Mechanisms of Viral Membrane Fusion Proteins: Multiple Variations on a Common ThemeStructure of Epstein-Barr Virus Glycoprotein 42 Suggests a Mechanism for Triggering Receptor-Activated Virus EntryCrystal Structure of the cis-Dimer of Nectin-1: IMPLICATIONS FOR THE ARCHITECTURE OF CELL-CELL JUNCTIONSStructure of Herpes Simplex Virus Glycoprotein D Bound to the Human Receptor Nectin-1Binding of herpes simplex virus glycoprotein D to nectin-1 exploits host cell adhesionStructural basis for the antibody neutralization ofHerpes simplex virusViral membrane fusion.Reevaluating herpes simplex virus hemifusion.Turning of the receptor-binding domains opens up the murine leukaemia virus Env for membrane fusion.Glycosaminoglycan interactions in murine gammaherpesvirus-68 infectionMultiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infectionInsertion mutations in herpes simplex virus 1 glycoprotein H reduce cell surface expression, slow the rate of cell fusion, or abrogate functions in cell fusion and viral entry.Insertion of a ligand to HER2 in gB retargets HSV tropism and obviates the need for activation of the other entry glycoproteins.Glycoprotein D actively induces rapid internalization of two nectin-1 isoforms during herpes simplex virus entryStructural basis of nectin-1 recognition by pseudorabies virus glycoprotein DLow pH-induced conformational change in herpes simplex virus glycoprotein B.Herpes simplex virus glycoproteins H/L bind to cells independently of {alpha}V{beta}3 integrin and inhibit virus entry, and their constitutive expression restricts infectionGlobal sensing of the antigenic structure of herpes simplex virus gD using high-throughput array-based SPR imaging.Repertoire of epitopes recognized by serum IgG from humans vaccinated with herpes simplex virus 2 glycoprotein DGlycoprotein B switches conformation during murid herpesvirus 4 entryHerpes B virus gD interaction with its human receptor--an in silico analysis approach.Herpesvirus glycoproteins undergo multiple antigenic changes before membrane fusion.Antibody-induced conformational changes in herpes simplex virus glycoprotein gD reveal new targets for virus neutralization.Herpes virus fusion and entry: a story with many characters.Herpes simplex virus glycoprotein D interferes with binding of herpesvirus entry mediator to its ligands through downregulation and direct competitionImpact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virusCrystal structure of herpes simplex virus 2 gD bound to nectin-1 reveals a conserved mode of receptor recognition.Construction and properties of a herpes simplex virus 1 designed to enter cells solely via the IL-13alpha2 receptorA herpes simplex virus recombinant that exhibits a single-chain antibody to HER2/neu enters cells through the mammary tumor receptor, independently of the gD receptors.Computational repositioning of ethno medicine elucidated gB-gH-gL complex as novel anti herpes drug target.
P2860
Q24313362-8F699FB6-B003-43F1-AAAC-D7D251E9BE17Q24604871-644715B8-C81A-4DDC-9876-72AF1ED64132Q24631036-8ED24D85-B386-45D1-8B82-222CDBF33611Q24645959-C75395CF-4F4F-4512-AD74-BC245DEB4EBCQ24672176-EAF0B326-B37C-4512-ADEB-8248BCE092BFQ24682681-1202736A-A88B-479C-9D84-A03A760DA356Q26750943-19148A71-6F5F-41E1-BE29-EB95CF56E0DEQ26765439-783F16EC-A88B-493F-9D63-71B4168D0060Q26774203-90B2E520-0601-4902-A88E-6C2C7E455535Q27480974-AD2785DC-0E60-44E7-8785-51FBC80B8DFDQ27487974-A9A000F6-BD37-401A-98A5-1F27C0D4FF00Q27653795-D4FEB958-8410-4991-8067-E65BD959BE60Q27666985-D313DDD3-1795-4AA9-BE15-30B6C171FAC9Q27674775-6D4F27BF-9DB6-4B7B-90EF-CEDCF105D08BQ27676007-70F67CD0-F2FE-46F2-BEE1-F8E4FB734BADQ27680164-0D897A61-1217-4671-B1A6-BB725BD56B17Q28080422-8CA4E565-2CF0-4125-83EC-BC75F8BAA85EQ30432548-BCD761DB-4D10-4994-9FEA-0ECF153A99F2Q30483804-5EFFE8FB-FC0C-4EF9-A9E9-5CE140901888Q33281001-2E8DA42B-673E-41EF-9DE8-E342AFDB8BA2Q33395218-A2185B44-349E-47C1-9C3F-6D05220773E0Q33614527-E7FF4E0E-58F9-495B-BF47-1F239037BCF9Q33621028-280AE60C-4040-4C9F-803D-A7D309D22398Q33695839-6C933D49-2BA1-4110-BFFD-93B8CBE62CBDQ33752109-8BB0B590-B4D0-4A90-9F12-53208CF51F97Q33769277-02519900-74BA-41A0-81EB-C950FA8C27D1Q33769324-D66E2A4F-6F37-49A8-A20A-3C8DB0683956Q33834821-6ACAACB1-AD1B-4FB5-97F0-E6C9FB66C42FQ33900262-FB64EBA7-04B6-49CE-B5F9-0744ECFE416AQ33918304-1A8BA458-D81B-49A6-B946-61ACDC430D9AQ33930801-723DD940-3E7A-4729-AB75-E5B5C95B32ABQ34131147-CE6A3502-1A88-45C1-9F5E-D1F315C6AA17Q34237174-CBC6031D-E31A-4E38-829C-66FEC3D556DDQ34285628-FA76AD35-947C-46F2-B163-68973DE50257Q34295959-4DC88847-28EA-4369-81C4-3AEC63827970Q34529794-B683B552-C3BA-479E-9366-82CB0B70FDBDQ34594121-1F20BF42-787A-46C4-8E25-09FB3E3827AAQ34600345-5E30AF07-C471-4589-893C-807650F4B81EQ34648103-5A73CC39-8CA1-4586-A453-AB814721A4FDQ34669211-FB6E82EB-36DC-407A-8BB9-7D598CBFCCF9
P2860
Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Structure of unliganded HSV gD ...... ted activation of virus entry.
@ast
Structure of unliganded HSV gD ...... ted activation of virus entry.
@en
Structure of unliganded HSV gD ...... ted activation of virus entry.
@nl
type
label
Structure of unliganded HSV gD ...... ted activation of virus entry.
@ast
Structure of unliganded HSV gD ...... ted activation of virus entry.
@en
Structure of unliganded HSV gD ...... ted activation of virus entry.
@nl
prefLabel
Structure of unliganded HSV gD ...... ted activation of virus entry.
@ast
Structure of unliganded HSV gD ...... ted activation of virus entry.
@en
Structure of unliganded HSV gD ...... ted activation of virus entry.
@nl
P2093
P2860
P50
P356
P1433
P1476
Structure of unliganded HSV gD ...... ated activation of virus entry
@en
P2093
Andrea Carfí
Don C Wiley
Gary H Cohen
J Charles Whitbeck
Sarah A Connolly
Vinit M Supekar
P2860
P304
P356
10.1038/SJ.EMBOJ.7600875
P407
P577
2005-11-17T00:00:00Z